Allworth Financial LP - XERIS PHARMACEUTICALS INC ownership

XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 106 filers reported holding XERIS PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Allworth Financial LP ownership history of XERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2021$1,000
-50.0%
5000.0%0.00%
Q2 2021$2,000
-81.8%
500
-79.0%
0.00%
Q1 2021$11,000
+83.3%
2,376
+82.8%
0.00%
Q4 2020$6,000
-25.0%
1,300
-7.1%
0.00%
Q3 2020$8,0001,4000.00%
Other shareholders
XERIS PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 3,000,641$29,496,0000.99%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 2,308,666$22,694,0000.92%
ArrowMark Colorado Holdings LLC 1,656,422$16,283,0000.16%
IHT Wealth Management, LLC 57,028$561,0000.08%
MOORE CAPITAL MANAGEMENT, LP 50,000$492,0000.02%
Engineers Gate Manager LP 20,264$199,0000.01%
FEDERATED HERMES, INC. 300,000$2,949,0000.01%
FMR LLC 4,048,102$39,793,0000.01%
Invesco Ltd. 1,000,000$9,830,0000.00%
MetLife Investment Management, LLC 14,041$138,0230.00%
View complete list of XERIS PHARMACEUTICALS INC shareholders